In this episode, Stacie Lindsey talks about the importance in understanding the recent FDA clearance of Praxis's Investigational New Drug (IND) - PRAX-222 EMBRAVE - that used patient data from Invitae Ciitizen in its clinical trial. This opens the doors for advancing research using data from patient registries, like ICPR.
cholangiocarcinoma.org
Create your
podcast in
minutes
It is Free